speb/financial-data huggingface dataset:
JAZZ income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 654661000.00
JAZZ income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 169742000.00
JAZZ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 696297000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 179169000.00
JAZZ income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 654661000.00
JAZZ income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 169742000.00
JAZZ income_statement (annual, 2025-12-31) — Diluted Average Shares: 60981000.00
JAZZ income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 63433000.00
JAZZ income_statement (annual, 2025-12-31) — Diluted EPS: -5.84
JAZZ income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.21
JAZZ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — EBIT: -432808000.00
JAZZ income_statement (quarterly, 2025-12-31) — EBIT: 253877000.00
JAZZ income_statement (annual, 2025-12-31) — EBITDA: 263489000.00
JAZZ income_statement (quarterly, 2025-12-31) — EBITDA: 433046000.00
JAZZ income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: -732000.00
JAZZ income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: -57000.00
JAZZ cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 6555000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 33000.00
JAZZ cash_flow (annual, 2025-12-31) — End Cash Position: 1391899000.00
JAZZ cash_flow (quarterly, 2025-12-31) — End Cash Position: 1391899000.00
JAZZ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -873380000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 75440000.00
JAZZ balance_sheet (annual, 2025-12-31) — Finished Goods: 141649000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Finished Goods: 141649000.00
JAZZ cash_flow (annual, 2025-12-31) — Free Cash Flow: 1146021000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 292289000.00
JAZZ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -2568000.00
JAZZ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -658000.00
JAZZ balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -568598000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -568598000.00
JAZZ balance_sheet (annual, 2025-12-31) — Goodwill: 1829340000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Goodwill: 1829340000.00
JAZZ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 6258850000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 6258850000.00
JAZZ balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 848041000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 848041000.00
JAZZ balance_sheet (annual, 2025-12-31) — Gross PPE: 437290000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 437290000.00
JAZZ income_statement (annual, 2025-12-31) — Gross Profit: 3764290000.00
JAZZ income_statement (quarterly, 2025-12-31) — Gross Profit: 1044398000.00
JAZZ cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 121808000.00
JAZZ balance_sheet (annual, 2025-12-31) — Income Tax Payable: 56387000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 56387000.00
JAZZ income_statement (annual, 2025-12-31) — Interest Expense: 195051000.00
JAZZ income_statement (quarterly, 2025-12-31) — Interest Expense: 45406000.00
JAZZ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 195051000.00
JAZZ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 45406000.00
JAZZ cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 248553000.00
JAZZ balance_sheet (annual, 2025-12-31) — Interest Payable: 40667000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Interest Payable: 40667000.00
JAZZ balance_sheet (annual, 2025-12-31) — Inventory: 416962000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Inventory: 416962000.00
JAZZ balance_sheet (annual, 2025-12-31) — Invested Capital: 9676841000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 9676841000.00
JAZZ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1509913000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -372162000.00
JAZZ cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
JAZZ cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
JAZZ balance_sheet (annual, 2025-12-31) — Land And Improvements: 72230000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 72230000.00
JAZZ balance_sheet (annual, 2025-12-31) — Leases: 63569000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Leases: 63569000.00
JAZZ balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 50892000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 50892000.00
JAZZ balance_sheet (annual, 2025-12-31) — Long Term Debt: 4328354000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4328354000.00
JAZZ balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4379246000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4379246000.00
JAZZ cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
JAZZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
JAZZ cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -781000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -7750000.00
JAZZ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 192976000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 192976000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -858053000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -125023000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
JAZZ balance_sheet (annual, 2025-12-31) — Net Debt: 3966358000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Net Debt: 3966358000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 203451000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -356148000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 203451000.00
JAZZ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -356148000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 203451000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -151000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -53500000.00
JAZZ income_statement (annual, 2025-12-31) — Net Interest Income: -195051000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Interest Income: -45406000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -470275000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -330100000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -781000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -7750000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -781000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -7750000.00
JAZZ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -195051000.00
JAZZ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -45406000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -75220000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1996000.00
JAZZ cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 28167000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 886220000.00
JAZZ balance_sheet (annual, 2025-12-31) — Net PPE: 258737000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Net PPE: 258737000.00
JAZZ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -58752000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -16729000.00
JAZZ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1940266000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1940266000.00
JAZZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 876680000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 876680000.00
JAZZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 594470000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 594470000.00
JAZZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 869130000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 869130000.00
JAZZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 594470000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 594470000.00
JAZZ income_statement (annual, 2025-12-31) — Normalized EBITDA: 1213919000.00
JAZZ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 433704000.00
JAZZ income_statement (annual, 2025-12-31) — Normalized Income: 394691700.00
JAZZ income_statement (quarterly, 2025-12-31) — Normalized Income: 204093335.21
JAZZ cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1355773000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 362518000.00
JAZZ income_statement (annual, 2025-12-31) — Operating Income: 517622000.00
JAZZ income_statement (quarterly, 2025-12-31) — Operating Income: 254535000.00
JAZZ income_statement (annual, 2025-12-31) — Operating Revenue: 4267586000.00
JAZZ income_statement (quarterly, 2025-12-31) — Operating Revenue: 1197926000.00
JAZZ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 61435000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 61435000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Current Assets: 323954000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 323954000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1029903000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1029903000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 4225000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 4225000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -568598000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -568598000.00
JAZZ income_statement (annual, 2025-12-31) — Other Income Expense: -950430000.00
JAZZ income_statement (quarterly, 2025-12-31) — Other Income Expense: -658000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4429510000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4429510000.00
JAZZ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1131455000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 40978000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 99030000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 99030000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 124519000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 124519000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Properties: 58880000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Properties: 58880000.00
JAZZ balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1050000000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1050000000.00
JAZZ income_statement (annual, 2025-12-31) — Other Special Charges: 947862000.00
JAZZ income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
JAZZ balance_sheet (annual, 2025-12-31) — Payables: 178448000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Payables: 178448000.00
JAZZ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 951913000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 951913000.00
JAZZ balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 215351000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 215351000.00
JAZZ balance_sheet (annual, 2025-12-31) — Prepaid Assets: 152481000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 152481000.00
JAZZ income_statement (annual, 2025-12-31) — Pretax Income: -627859000.00
JAZZ income_statement (quarterly, 2025-12-31) — Pretax Income: 208471000.00
JAZZ cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 107863000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 85186000.00
JAZZ balance_sheet (annual, 2025-12-31) — Properties: 0.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
JAZZ cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 19108000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 4114000.00
JAZZ cash_flow (annual, 2025-12-31) — Purchase Of Business: -858053000.00
JAZZ cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -151000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -53500000.00
JAZZ cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1830275000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -510100000.00
JAZZ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -58752000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -16729000.00
JAZZ balance_sheet (annual, 2025-12-31) — Raw Materials: 21963000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Raw Materials: 21963000.00
JAZZ balance_sheet (annual, 2025-12-31) — Receivables: 830747000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Receivables: 830747000.00
JAZZ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 461660000.00
JAZZ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 144101000.00
JAZZ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 696297000.00
JAZZ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 179169000.00
JAZZ cash_flow (annual, 2025-12-31) — Repayment Of Debt: -781000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -7750000.00
JAZZ cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -125023000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
JAZZ income_statement (annual, 2025-12-31) — Research And Development: 782736000.00
JAZZ income_statement (quarterly, 2025-12-31) — Research And Development: 213909000.00
JAZZ balance_sheet (annual, 2025-12-31) — Retained Earnings: 646176000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 646176000.00
JAZZ cash_flow (annual, 2025-12-31) — Sale Of Investment: 1360000000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 180000000.00
JAZZ income_statement (annual, 2025-12-31) — Selling General And Administration: 1809271000.00
JAZZ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 406212000.00
JAZZ balance_sheet (annual, 2025-12-31) — Share Issued: 61435000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Share Issued: 61435000.00
JAZZ income_statement (annual, 2025-12-31) — Special Income Charges: -947862000.00
JAZZ income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
JAZZ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 291133000.00
JAZZ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 70854000.00
JAZZ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4318584000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4318584000.00
JAZZ balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1940266000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1940266000.00
JAZZ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -199590300.00
JAZZ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -15664.79
JAZZ income_statement (annual, 2025-12-31) — Tax Provision: -272443000.00
JAZZ income_statement (quarterly, 2025-12-31) — Tax Provision: 4963000.00
JAZZ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
JAZZ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
JAZZ balance_sheet (annual, 2025-12-31) — Total Assets: 11659340000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Assets: 11659340000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Capitalization: 8646938000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8646938000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Debt: 5423866000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Debt: 5423866000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4318584000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4318584000.00
JAZZ income_statement (annual, 2025-12-31) — Total Expenses: 3749964000.00
JAZZ income_statement (quarterly, 2025-12-31) — Total Expenses: 943391000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 7340756000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7340756000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7493297000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7493297000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5098235000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5098235000.00
JAZZ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -430240000.00
JAZZ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 254535000.00
JAZZ balance_sheet (annual, 2025-12-31) — Total Tax Payable: 56387000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 56387000.00
JAZZ income_statement (annual, 2025-12-31) — Total Unusual Items: -950430000.00
JAZZ income_statement (quarterly, 2025-12-31) — Total Unusual Items: -658000.00
JAZZ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -950430000.00
JAZZ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -658000.00
JAZZ balance_sheet (annual, 2025-12-31) — Work In Process: 253350000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Work In Process: 253350000.00
JAZZ balance_sheet (annual, 2025-12-31) — Working Capital: 1923522000.00
JAZZ balance_sheet (quarterly, 2025-12-31) — Working Capital: 1923522000.00
JAZZ income_statement (quarterly, 2026-03-31) — +Operating Expense: 598200000.00
JAZZ income_statement (quarterly, 2026-03-31) — +Total Revenue: 1068900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 100000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 836300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -181700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4244000000.00
JAZZ income_statement (quarterly, 2026-03-31) — Amortization: 172300000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 172300000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 172300000.00
JAZZ income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 172300000.00
JAZZ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 61900000.00
JAZZ income_statement (quarterly, 2026-03-31) — Basic EPS: 4.73
JAZZ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1391900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -19700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 62200000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1844300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2874300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1176800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Cash Financial: 667500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -78500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 123100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 408200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -21400000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -7900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 37400000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Inventory: -77800000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 12200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Payable: 16000000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 8100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 51900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Receivables: -6500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 37400000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -12100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -6500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Changes In Cash: 452800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Common Stock: 100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4532300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 60100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 134100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 790200000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Assets: 4583100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 14900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Debt: 1030500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1045400000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2246600000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Current Provisions: 26600000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -66200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Deferred Tax: -66200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Depreciation: 9100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 181400000.00
JAZZ income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 172300000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 181400000.00
JAZZ income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 172300000.00
JAZZ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 66100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.43
JAZZ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — EBIT: 339100000.00
JAZZ income_statement (quarterly, 2026-03-31) — EBITDA: 520500000.00
JAZZ income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 0.00
JAZZ cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -400000.00
JAZZ cash_flow (quarterly, 2026-03-31) — End Cash Position: 1844300000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -78500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Finished Goods: 119500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 388500000.00
JAZZ income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -651000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Goodwill: 1805000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6008800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Gross PPE: 440600000.00
JAZZ income_statement (quarterly, 2026-03-31) — Gross Profit: 934800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 93700000.00
JAZZ income_statement (quarterly, 2026-03-31) — Interest Expense: 39900000.00
JAZZ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 39900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Interest Payable: 21400000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Inventory: 437500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9887000000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 123100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 71800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Leases: 63600000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 47300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4324200000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4371500000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -7800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 189300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Net Debt: 3510400000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 293100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 293100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 293100000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Interest Income: -39900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 220000000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -7800000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -7800000.00
JAZZ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -39900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -103600000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -77200000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Net PPE: 258900000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -19700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1476500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 914100000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 547700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 907000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 547700000.00
JAZZ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 518000000.00
JAZZ income_statement (quarterly, 2026-03-31) — Normalized Income: 290650969.25
JAZZ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 408200000.00
JAZZ income_statement (quarterly, 2026-03-31) — Operating Income: 336600000.00
JAZZ income_statement (quarterly, 2026-03-31) — Operating Revenue: 1068900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 62700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 285300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1030500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 8500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -651000000.00
JAZZ income_statement (quarterly, 2026-03-31) — Other Income Expense: 2500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4203800000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -76700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 94700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 161500000.00
JAZZ income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -122800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Properties: 55800000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1030000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Payables: 193700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 983900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 182200000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 149700000.00
JAZZ income_statement (quarterly, 2026-03-31) — Pretax Income: 299200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 32900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
JAZZ cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 14200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
JAZZ cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -500000000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -19700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Raw Materials: 27600000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Receivables: 836300000.00
JAZZ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 125000000.00
JAZZ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 181400000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -7800000.00
JAZZ income_statement (quarterly, 2026-03-31) — Research And Development: 196000000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 939200000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 720000000.00
JAZZ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 352700000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Share Issued: 62700000.00
JAZZ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 74500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4532300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1476500000.00
JAZZ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 50969.25
JAZZ income_statement (quarterly, 2026-03-31) — Tax Provision: 6100000.00
JAZZ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Assets: 11859600000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8856500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Debt: 5416900000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4532300000.00
JAZZ income_statement (quarterly, 2026-03-31) — Total Expenses: 732300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7327300000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7276500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5080700000.00
JAZZ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 336600000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 93700000.00
JAZZ income_statement (quarterly, 2026-03-31) — Total Unusual Items: 2500000.00
JAZZ income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2500000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Work In Process: 290400000.00
JAZZ balance_sheet (quarterly, 2026-03-31) — Working Capital: 2336500000.00
JBCHEPHARM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 154576815.00
JBCHEPHARM.NS income_statement (annual, 2022-03-31) — Basic EPS: 24.93
JBCHEPHARM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 154700923.00
JBCHEPHARM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 24.91
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 954000.00
JBCHEPHARM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 455180000.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
JBCHEPHARM.NS cash_flow (annual, 2022-03-31) — Sale Of Intangibles: 0.00
JBCHEPHARM.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 216934000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 13442194000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 31165056000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2386476000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 5757974000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -6434920000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 712098000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -45765000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 136203000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 77324995.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Basic EPS: 26.50
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 565441000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 3313317000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -7649470000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 242079000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 154755000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 769344000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2692038000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -1275926000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 269118000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 500226000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -205232000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 323496000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -417466000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -299202000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 203617000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 154755000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -1275926000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 24803522000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 84827000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 468719000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 11847974000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 15280330000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 88869000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1650180000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1739049000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 5544493000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 425005000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Depreciation: 1144069000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1144069000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1144069000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1144069000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 78308798.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 26.17
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 4098355000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 18784000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 30000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — EBIT: 5906410000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — EBITDA: 7050479000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 286000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 769344000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 137841000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 3565380000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 1817357000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1393349000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -69028000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -72000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 367918000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 574592000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 13797402000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 5803739000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 12223769000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Gross Profit: 19317082000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 6154000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Interest Expense: 354084000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 354084000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Interest Income: 25362000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 25362000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -322292000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 21801000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Inventory: 4304843000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 30285905000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -9617884000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 274044000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 84827000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 6086268000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 70761000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 153210000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 3832203000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 3985413000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 6086268000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -872500000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 152100000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 7533323000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Minority Interests: -1698000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 84827000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 4713039000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -158327000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income: 4098355000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 4098355000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 4100053000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 4098355000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 4098355000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 5552326000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 4100053000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -6923784000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -335169000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -1998604000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 5231596000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 5213768000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -335169000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -55798000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 5788849000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -717327000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 17828000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 11006120000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 24927000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 65102000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1028237000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 152114000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 58928000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 6974738000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Normalized Income: 4042424906.15
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 6256121000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Operating Income: 5874888000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 31165056000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 154755168.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 27000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 236500000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1216210000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 13222810000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 458435000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 311938000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 33700000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 25000000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 3658000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3038827000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 755614000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 837649000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 289654000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1922694000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -6743000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Payables: 3210410000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 425100000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 2210856000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Pretax Income: 5552326000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 35470000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -6923784000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -7568709000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -725686000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1668106000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 11847974000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1144069000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 29508000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 29508000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -872500000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 18784000.00
JBCHEPHARM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 21250814000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 5570105000.00
JBCHEPHARM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 8359000.00
JBCHEPHARM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 3384979000.00